HEALTHCARE & MEDICARE
-
Morgan Health: 5 predictions for employer-sponsored insurance in 2026
Morgan Health CEO Dan Mendelson said health care costs have been a major challenge for employers through 2025 and are…
Read More » -
Knowledge is power: How early detection is transforming Alzheimer’s care
Few diseases affect as many people as Alzheimer's disease. The diagnosis has long been viewed as a devastating sentence, leading…
Read More » -
Valerie Health raises $30M to advance AI front office for independent provider groups
Valerie Health, an AI-powered front office for independent provider groups, announced last week that it had raised $30 million in…
Read More » -
Why artificial intelligence underperforms hospital patient engagement
New research shows that health systems are struggling to effectively use artificial intelligence to improve patient engagement. The study, released…
Read More » -
When innovation transcends regulation: Lessons from IV spas to artificial intelligence
We hear that in addition to “changing the world,” innovation must “move fast and break things.” This feels like gospel…
Read More » -
The staffing crisis safety teams aren't talking about: When safety concerns lead to an exodus of health care workers
Many healthcare executives are familiar with the numbers: According to the 2025 NSI National Healthcare Retention and Registered Nurse Staffing…
Read More » -
Santa reminds us we can do better – Healthcare Blog
Author: Mike Magee The ghost of Christmas past, in the form of Surgeon General C. Everett Koop, returns this season…
Read More » -
Deloitte Healthcare Outlook 2026: Key findings on confidence, digital health, AI and partnerships
A recent Deloitte report shows that more than two-thirds of health plan and health system leaders expect to outperform their…
Read More » -
AHA invests in artificial intelligence to address gender bias in cardiology
Over the past decade, healthcare leaders have become increasingly aware of the fact that cardiology has a significant gender bias…
Read More » -
FDA approves new cytodynamic heart drug to compete with fast-growing BMS Med
Before the FDA makes a decision on Cytokinetics' obstructive hypertrophic cardiomyopathy drug, the open question is not whether the FDA…
Read More »